| Literature DB >> 32307017 |
Omar Jmour1, Marouan Benna1, Pierre Champagnol1, Majed Ben Mrad1, Anis Hamrouni1, Layal Obeid1, Chaimaa Lahmamssi1, Amal Bousarsar1, Nicolas Vial1, Amel Rehailia-Blanchard1, Sandrine Sotton1, Meiling Lan1, Julien Langrand-Escure1, Alexis Vallard1, Nicolas Magné2.
Abstract
BACKGROUND: In most clinical trials, gold fiducial markers are implanted in the prostate to tune the table position before each radiation beam. Yet, it is unclear if a cone-beam computed tomography (CBCT) should be performed before each beam to monitor a possible variation of the organs at risk (OARs) fullness, especially in case of recto-prostatic spacer implantation. The present study aimed at assessing the inter- and intra-fraction movements of prostate, bladder and rectum in patients implanted with a hyaluronic acid spacer and undergoing prostate stereotactic body radiotherapy (SBRT).Entities:
Keywords: Bladder; Cone beam CT, motion; Organs at risk; Prostate cancer; Radiotherapy; Rectum; Stereotactic body radiotherapy
Mesh:
Substances:
Year: 2020 PMID: 32307017 PMCID: PMC7168857 DOI: 10.1186/s13014-020-01534-2
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Magnitude of table displacement performed after the CBCTs in order to target the prostate (matching on gold fiducials)
| CBCT performed before the first arc | CBCT performed before the second arc | |||||
|---|---|---|---|---|---|---|
| Antero-posterior | Supero-inferior | Left-Right | Antero-posterior | Supero-inferior | Left-Right | |
| Minimum value (cm) | −0.89 | − 0.60 | −1.96 | −1.80 | − 0.37 | − 0.40 |
| Maximum value (cm) | + 0.88 | + 0.45 | + 0.51 | + 1.64 | + 0.28 | + 1.79 |
| Mean value± Standard deviation (cm) | 0.06 ± 0.35 | −0.04 ± 0.26 | 0.00 ± 0.27 | −0.03 ± 0.34 | −0.07 ± 0.13 | 0.04 ± 0.23 |
| Interval including 95.4% of values (cm) | ||||||
| Lower boundary | −0.63 | −0.56 | − 0.55 | −0.70 | − 0.32 | −0.42 |
| Upper boundary | + 0.76 | + 0.49 | + 0.55 | + 0.65 | + 0.19 | + 0.51 |
| Proportion of table displacement exceeding the CTV/PTV margin (0.4 cm), % | 35% | 30% | 17.5% | 12.5% | 5% | 15% |
Fig. 1Evolution of the mean bladder volume before and during SBRT fraction, compared to the bladder on planning CT-scan. The bladder volume assessed on the planning CT-scan divided the bladder volume assessed on the CBCT performed before the first (blue line) and the second arc (orange line) (1 = volumes were equal)
Fig. 2Individual data about the evolution of the bladder volume assessed during SBRT fraction, compared to the bladder assessed before SBRT fraction. The bladder volume assessed on the CBCT performed before the first arc divided the bladder volume assessed on the CBCT performed before the second arc (1 = volumes were equal). Abbreviation: P: Patient
Fig. 3Evolution of the mean rectum volume assessed before and during SBRT fraction, compared to the rectum on planning CT-scan. The rectum volume assessed on the planning CT-scan divided the rectum volume assessed on the CBCT performed before the first (blue line) and the second arc (orange line) (1 = volumes were equal)
Fig. 4Individual data about the evolution of the rectal volume assessed during SBRT fraction, compared to the rectum assessed before SBRT fraction. The rectal volume assessed on the CBCT performed before the first arc divided the rectal volume assessed on the CBCT performed before the second arc (1 = volumes were equal). Abbreviation: P: Patient
Fig. 5Example of the effect of hydrogel rectal spacer (blue), preventing the rectal wall to move anteriorly. The prostate is in pink, the bladder in yellow